Related Experiment Video
Updated: Nov 16, 2025

14:58
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
4.6K
Genomic Expression Profiling and Bioinformatics Analysis of Chronic Recurrent Multifocal Osteomyelitis
Kai Huang1, Bingyuan Lin1, Yiyang Liu1
1Department of Orthopaedics, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Biomed Research International
|February 25, 2021
Summary
Chronic recurrent multifocal osteomyelitis (CRMO) involves altered immune responses and cellular energy pathways. Key genes in oxidative phosphorylation, ribosome function, and immune signaling may drive this autoinflammatory bone disease.
Area of Science:
- Genomics
- Immunology
- Molecular Biology
Background:
- Chronic nonbacterial osteomyelitis (CNO) is an autoinflammatory bone disorder, with chronic recurrent multifocal osteomyelitis (CRMO) being its most severe form.
- The precise molecular mechanisms underlying CNO/CRMO pathogenesis remain largely unknown.
- Current diagnostic and treatment strategies for CNO/CRMO lack standardization.
Purpose of the Study:
- To identify differentially expressed genes (DEGs) in CRMO tissues compared to normal controls.
- To elucidate the molecular pathophysiology of CRMO.
- To uncover potential diagnostic and therapeutic targets for CRMO.
Main Methods:
- Microarray data analysis of CRMO and normal tissue samples from the GSE133378 dataset.
- Identification of DEGs using the limma package in R.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, alongside protein-protein interaction (PPI) network analysis.
Main Results:
- A total of 1299 differentially expressed mRNAs were identified, with 1177 upregulated and 122 downregulated genes.
- GO analyses revealed enrichment in immune-related terms.
- KEGG pathway analyses highlighted associations with oxidative phosphorylation, ribosome, and Parkinson disease pathways. Immune and ribosomal gene modules were identified.
Conclusions:
- Oxidative phosphorylation, ribosome, and Parkinson disease pathways are significantly associated with CRMO.
- Immune-related genes (e.g., IRF5, OAS3, HLA-A) and ribosomal genes may play a role in CRMO pathogenesis.
- Identified genes offer potential for developing early diagnostic tools, prognostic markers, or therapeutic strategies for CRMO.

